Skip to main content
Clinical Trials/NCT00734838
NCT00734838
Completed
Not Applicable

Optical Spectroscopy During Breast Cancer Surgery and Core Needle Biopsy

Duke University1 site in 1 country213 target enrollmentJanuary 2006
ConditionsBreast Cancer

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Breast Cancer
Sponsor
Duke University
Enrollment
213
Locations
1
Primary Endpoint
Optical signatures
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

The objective of the proposed research is to develop new diagnostic modalities based on optical spectroscopy (auto fluorescence, absorption, and scattering) for the diagnosis of breast cancer and test its performance as an adjunct to core needle biopsy. For the surgery part of the study, all patients scheduled to have a mastectomy or lumpectomy for the treatment of breast cancer will be asked if they would be willing to participate in this study. For the core needle biopsy part of the study, patients with a higher pre-probability of cancer (based on mammography) will be recruited to increase the number of patients with malignant lesions and enrolled in this investigation.

Registry
clinicaltrials.gov
Start Date
January 2006
End Date
October 3, 2022
Last Updated
2 years ago
Study Type
Interventional
Study Design
Parallel
Sex
Female

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Patients having a needle biopsy of a breast mass

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Optical signatures

Time Frame: Day of procedure (less than 10 minutes)

The primary outcome of this study is the identification of the optical signatures of normal and cancerous tissue of the breast

Study Sites (1)

Loading locations...

Similar Trials